MJA Group Australia is owned and operated by the Australasian Medical Publishing Company (AMPCo), a wholly-owned subsidiary of the Australian Medical Association.
Med J Aust 2015
The real question is whether a person who is suffering pain and distress can access cannabis on their own initiative, following medical consultation as to their symptoms. They can access other herbal remedies from authorised providers such as health food stores or a pharmacist. If legislation permits sale to people suffering from a condition diagnosed by a doctor and scheduled in legislation, there should be no problem with provision of cannabis by this route without waiting for completion of a clinical trial. This is especially the case with Dravet syndrome patients where a formal clinical trial with a proprietary CBD concentrate may take several years to complete.
We should ensure that cannabis is provided only to approved users who should be registered. As there is no legal supplier, users should have permission to grow their own plants — up to 10 at any one time — but be forbidden from selling their product.
https://www.mja.com.au/journal/2015/202/2/medical-cannabis-time-clear-thinking
users should have permission to grow their own plants — up to 10 at any one time
😛 thats one step forward, a few more in the same direction will make it legal for raw treatments.
eg. recommended–> 30 plants for 30 day treatment of 30mil of cannabis juice a day.
-
This topic was modified 9 years, 1 month ago by Radic.